Nureca Ltd. · NSE:NURECA

Nureca — Q2 FY2026 Earnings Presentation

28 slides from Nureca's earnings presentation, Oct 16, 2025

  1. Slide 1: Investor Presentation (Q2'FY26) exchange cover letter

    NURECA www.nureca.com Dated - 16.10.2025 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 S

  2. Slide 2: Investor Presentation Q2 FY26

    NURECA Investor Presentation Q2 FY 26 Trust What's Best For Your Health

  3. Slide 3: Disclaimer

    NURECA Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation tha

  4. Slide 4: Our Vision and Mission

    NURECA Our Vision To be a global leader in healthcare innovation, empowering individuals to take control of their well-being through cutting-edge technology, accessible solutions, and an unwavering commitment to excellence in quality and service. our Mission To provide world-class healthcare solutio

  5. Slide 5: Table of Contents

    Table of Contents Highlights of Q2 & FY 26 Business Highlights Business Performance - Q2 & H1 26 Industry Landscape Growth Drivers

  6. Slide 6: Financial Performance

    NURECA We are a Digital First Healthcare Company with more than 93% revenue generated by Online sales Nureca is a debt-free, asset light company and has a healthy liquidity position. Financial Performance Revenue from Operations EBITDA Profit After Tax e Q2FY 26 - INR528 Mn e Q2FY 26 - INR 377 Mn e

  7. Slide 7: Business Highlights

    NURECA Business Highlights

  8. Slide 8: 3P Interplay Generating Business MOAT

    3P Interplay Generating Business MOAT (3P -Product - Placement — Promotion) Internal Strengths Curated Over the Years Across Product Design, Supply Chain, Distribution and Marketing is Onerous to Replicate Sustained focus on Innovation and Quality Products M Integrated Manufacturing Ecosystem < ¥ 8

  9. Slide 9: Strategic Pillars

    Strategic Pillars D2C growth Omnipresence Manufacturing Connected Health Expand our already strong Establish pan India sales Building a strong manufacturing Transform lives of our users presence online by network with expansive reach base in India with focus on quality, through our Connected innovat

  10. Slide 10: D2C growth

    NURECA l. D2C growth Our growing digital customer base Our customer base has grown exceptionally over the last 5 years which is a result of remarkable quality of our o 90% £ 2 products that led to word-of-mouth marketing by our loyal customer base. Currently, our products have more Revenue Contribut

  11. Slide 11: Diving into Our Products Portfolio

    NURECA Diving into Our Products Portfolio Massagers Manipol Supervolt Go Gun Dynamo Rechargeable Gun Foot, Leg and Calf ~ TENStar Tens Massager Neck and Shoulder Weighing & Kitchen Scales 8 Electrode smart Legend Smart Scale Hercules Scale Unbeatable Scale Electronic Kitchen Scale Kitchen Scale N sc

  12. Slide 12: Product Portfolio (Orthopedic, Baby Care, Respiratory)

    Orthopedic Range-1 i ‘ Leg Elevation Maternity Backrest Neck Pillow for Backrest Pillow Wedge Pillow Support Pillow Wedge Pillow travelling Knee Pillow Orthopedic Range-1I Neck rest Car Neck Stretcher Heating Pads > Memory Memory Foam m Foam Pillow Cervical Pillow cervical Pillow Pillow Pillow. with

  13. Slide 13: New Launches

    New Launches Check Pregnancy Pillow - J Pregnancy Pillow Yawnicorn Cuddle | ou r @ Shaped Pillow P t’ y Shaped Health = In Seconds. & Dr Trust No-touch Infrared Pet Thermometer Shop Now Supervolt Octacore massager Rechargeable Scalp Massager with Non-Contact Infrared Pet Red Light Therapy Thermomete

  14. Slide 14: Manufacturing

    Il. Manufacturing Our wholly owned manufacturing subsidiary Nureca Technologies Pvt Limited , stared operations in Apr'22. USFDA Registration No.: 3036779619 Products categories manufactured at NTPL: 1. Blood Pressure Monitors Nebulizers N Electric Massagers w Oral and Infrared Thermometers M Heatin

  15. Slide 15: Omnipresence

    NURECA lll. Omnipresence Expanding Offline Distribution Over the years, our brand, Dr Trust, has garnered substantial recognition and commendation across e-commerce platforms. By capitalizing on this positive momentum, we anticipate a notable upswing in our retail trade network. We are in the proces

  16. Slide 16: Connected Health

    NUREgA Good evening ritu v DrTrust _ Smart IV. Connected Health Dr Trust 360 is not just an app, it's a comprehensive health management companion that empowers users to take control Quick Measure of their health through technology. . . voayoomposi| [] B oy =} Weight Kitchen BP A Weight By connecting

  17. Slide 17: Dr Trust 360 Freemium Connected Health app

    DrTrust 366 Freemium Connected Health app Our unified app is a Freemium model, where users are able to subscribe for Pro features like Advanced health reports, curated diet plans, calorie & water intake tracking, family & caregiver alerts on Whatsapp F F t Allows Users to access basic features at no

  18. Slide 18: Rewards & Recognition

    NURECA Rewards & Recognition > Dr Trust, Nureca’s flagship brand, has been ranked by customers as India’'s number one brand in the category of Home Healthcare and Wellness. > Dr Trust awarded in Best Healthcare Brands 2021 by Economic Times, Premium Prestigious Brands 2020 by Economic Times and in M

  19. Slide 19: Business Performance

    Business Performance

  20. Slide 20: Key Performance Indicators (Consolidated)

    NURECA Key Performance Indicators (Consolidated) Revenue from Operations( Z Crore) EPS (3) 62 255.5 111.3 109.7 91.9 71.9 4.43 — s - 085 -8.3 -1.8 2021 2122 22 2324 225 2526 (H1) | | | | | 20-21 21-22 2223 23-24 24-25 25-26 (H1) Fixed Asset (ZCrore) PAT ( Crore) ‘e 50 152 106 87 %0 7.4 4.4 0.9 - 4.0

  21. Slide 21: Key Performance Indicators (Consolidated)

    NURECA Key Performance Indicators (Consolidated) ROCE Working Capital Turnover 30% EBITDA % 67% 24% 57% 33% 10% 4% 0.6 0.4 --5% -1% 2021 2022 III- 2023 2024 2025 H1 2026 2021 2022 - 26% 0% 2024 2025 H1 2026 2020 2021 2022 2023 2024 2025 PAT % Return on Equity 2% 52.1% 17% 24.6% 6% 1% —_— - . 04% 2.3

  22. Slide 22: Key Performance Indicators (Consolidated)

    NURECA Key Performance Indicators (Consolidated) Current Ratio Debtor Turnover Ratio (Days) 209 20.8 15 16.8 15.3 gl 22 8 “ 8.2 2021 2022 2023 2024 2025 H1 2026 2021 2022 2023 2024 2025 H1 2026 Inventory Turnover Ratio Debt To Equity Ratio 43 3.7 2.7 1.9 1.9 002 002 002 oo 003 I : 2020 2021 2022 202

  23. Slide 23: Cash flow bridge

    NURECA INR in Million CEIEEEND 45 -67 2 12 EEE e Net cash Closing Cash as Net cash outflow on 30th outflow towards September 2025 Opening Cash towards Netcash flow financing as on Ist April operating from investing activities 2025 octirities activities | , || l _— Payment of lease liabilities (1) |

  24. Slide 24: NURECA

    NURECA

  25. Slide 25: Market Size for HealthCare Products in India & Neighboring Countries

    NURECA Market Size for HealthCare Products in India & Neighboring Countries, 2025-2030E (in Crore) Self Monitoring Glucose Devices CAGR 2025-2030E (9.9%) 5203 W Digital and Infrared Thermometers M Humidifiers and Steamers Pulse Oximeters 1408 Nebulizers 3559 1315 I Weighing & Kitchen Scales* 3240 12

  26. Slide 26: Digitization of Sales Process Generated a Virtuous Flywheel

    NURECA Digitization of Sales Process has Generated a Virtuous Flywheel enabling Faster Speed to Market Product Design E Manufacturing Ecosystem =2 Distribution E Marketing Digitization Our Data Centric Approach allows us to : Improved Customer e leveraging Consumer InvestmentinD2C & Engagements Insi

  27. Slide 27: Growth Drivers Going Forward

    NURECA Growth Drivers Going Forward Boosting Quick Commerce Reach and Market Penetration Driving In-house Manufacturing with Cutting-edge DrTrust USA Quality Innovations Drive Market Growth with New Product Launches and thereby Increase value proposition to customers Drive Deeper Market Penetration

  28. Slide 28: Thank You

    NURECA Thank You Contact Us Investor Relations | D Trustusa Nishu Kansal \¥ investor@nureca.com OR TH OP ED IC[ i 3 . Address Website HEAT BELT (BLUE) B3 Office No. 101, Udyog Bhavan, Corporate: www.Nureca.com Sonawala Lane, Goregaon East, Ecom Store: www.drtrust.in Mumboai, Maharashtra - 400063

Nureca — Q2 FY2026 Earnings Presentation on 6ix